Survey of nocturnal reflux in patients with gastroesophageal reflux disease in China

J Dig Dis. 2019 Nov;20(11):589-595. doi: 10.1111/1751-2980.12820.

Abstract

To evaluate current diagnosis and treatment of patients with nocturnal gastroesophageal reflux (nGER).

Methods: This multicenter observational study was conducted in 44 hospitals in China from May 2017 to February 2018. Outpatients with nGER were recruited and their relevant data were collected using a questionnaire, including age, gender, body mass index, history of smoking and alcohol consumption, comorbid diseases, lifestyle, self-reported health status, medical history, nGER symptoms and severity, Hospital Anxiety Depression Scale, Pittsburgh Sleep Quality Index, diagnosis and treatment choices. The study was registered on the Chinese Clinical Trial Registry (no. ChiCTR1800017525).

Results: The study included 4978 individuals, with valid questionnaires collected from 4448 patients (89.4%). The symptoms of heartburn and regurgitation were more severe at night than during the day (P < 0.05). Age and body mass index were positively correlated with reflux severity at night and during the day (P < 0.05). The severity of nGER was positively associated with lifestyle factors such as smoking, a high-fat diet, carbonated beverage consumption, late supper (later than 9 pm), and snoring (all P < 0.05). Night-time heartburn and regurgitation were related with sleep disorder.

Conclusions: Lifestyle factors are associated with nGER severity, and nGER affects sleep quality. It will be beneficial to popularize and strengthen the diagnosis and treatment of nGER.

Keywords: epidemiology; gastroesophageal reflux; psychometrics; sleep.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Comorbidity
  • Female
  • Gastroesophageal Reflux / epidemiology*
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Proton Pump Inhibitors / therapeutic use
  • Psychometrics
  • Severity of Illness Index
  • Sleep
  • Time Factors

Substances

  • Proton Pump Inhibitors